Urgent.News

What's breaking now, across thousands of outlets.

AI

Google DeepMind Publishes AI-Powered Predictions For Effect of All 9 Billion Mutations to Human DNA

Google DeepMind has released AlphaGenome Atlas, a free research database containing AI-generated predictions for the effects of all 9 billion possible single-letter mutations in the human genome. Built from its AlphaGenome model, the atlas is designed to help scientists interpret both protein-coding and harder-to-understand regulatory DNA. Fortune reports: AlphaGenome Atlas, as DeepMind calls the…

Google DeepMind has launched AlphaGenome Atlas, a free online resource containing AI-generated predictions for the effects of all 9 billion possible single-letter mutations in the human genome. This comprehensive database, built using DeepMind's AlphaGenome model, aims to assist scientists in interpreting both protein-coding and more complex regulatory DNA sequences.

Previously, researchers had to analyze each variant individually or conduct laboratory tests, which proved to be a time-consuming and laborious process. AlphaGenome Atlas simplifies this task, enabling biologists and medical researchers to access a precomputed catalogue of potential mutation impacts within minutes.

This groundbreaking tool promises to accelerate our understanding of genetic diseases and hasten the discovery of potential cures. Pushmeet Kohli, DeepMind's vice president for research and head of its AI for science team, emphasized that this release is the first of its kind, providing the world with a complete map of human genetic variation through a simple web browser.

Kohli likened the project to completing the unfinished business of the Human Genome Project, which mapped the entire human DNA sequence in 2003 but left many unanswered questions about how to interpret the data. AlphaGenome Atlas is now accessible for non-commercial use via a dedicated website. The company plans to make it available for commercial use through a licensing agreement with Google Cloud in the near future.

Isomorphic Labs, DeepMind's sister company focused on AI-driven drug discovery, will have access to the Atlas but will also require a commercial license for its usage. A paper detailing the development and functionality of the Atlas has been submitted to bioRxiv, a platform for preprint academic papers in the biomedical field.

Written by urgent.news from Slashdot's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at tech.slashdot.org →

More in AI

More from Tuesday 8 September →